Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
Secured over $111 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by over $71 million in committed capital from Medtronic and Ligand Achieved multiple FD... [18801 chars]